peoplePerson
A. Keith Stewart
Keith Stewart is a myeloma researcher who leads Canada's largest cancer centre.
Led the ASPIRE trial of carfilzomib in relapsed myeloma and myeloma genomics studies; returned from Mayo Clinic to direct the Princess Margaret in 2021.
Role
Director, Princess Margaret Cancer Centre; Vice President, Cancer, University Health Network
Institution
Specialisms
Multiple myelomaCancer genomicsAcademic leadership
Profiles
| Title | Journal | Year |
|---|---|---|
| Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma | New England Journal of Medicine | 2015 |
Pages like this
not linked directly; found by shared links- PersonSundar Jagannath
Shares Carfilzomib, Multiple myeloma.
- ProductIberdomide
Shares Lenalidomide, Multiple myeloma.
- PersonPaul G. Richardson
Shares Lenalidomide, Multiple myeloma.
- PersonKenneth C. Anderson
Shares Lenalidomide, Multiple myeloma.
- TrialCEPHEUS
Shares Lenalidomide, Multiple myeloma.
- TrialIMROZ
Shares Lenalidomide, Multiple myeloma.
- IdeaMRD-guided treatment-free intervals in myeloma
Shares Lenalidomide, Multiple myeloma.
- PersonBenjamin L. Ebert
Shares Lenalidomide, Multiple myeloma.